SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-107397
Filing Date
2009-05-11
Accepted
2009-05-11 17:27:32
Documents
8
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 480649
2 SETTLEMENT AGREEMENT AND MUTUAL RELEASE dex10318.htm EX-10.318 76667
3 RESEARCH AND LICENSE AGREEMENT dex10319.htm EX-10.319 135935
4 SEPARATION AGREEMENT dex10320.htm EX-10.320 52176
5 CERTIFICATION dex311.htm EX-31.1 6251
6 CERTIFICATION dex312.htm EX-31.2 6249
7 CERTIFICATION dex321.htm EX-32.1 4261
8 CERTIFICATION dex322.htm EX-32.2 4263
  Complete submission text file 0001193125-09-107397.txt   767864
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 09816392
SIC: 2834 Pharmaceutical Preparations